Universal Health Services, Inc.’s Stock Price Soars to $177.05, Marking a Robust 4.47% Increase

Universal Health Services, Inc. (UHS)

177.05 USD +7.58 (+4.47%) Volume: 0.71M

Universal Health Services, Inc.’s stock price is currently standing strong at 177.05 USD, showcasing a positive surge of +4.47% this trading session with a trading volume of 0.71M. The stock has demonstrated robust year-to-date performance, achieving a notable gain of +16.14%, indicating a promising investment opportunity in the healthcare sector.

Latest developments on Universal Health Services, Inc.

Universal Health Services Inc. Cl B stock has been underperforming in the market compared to its competitors this Tuesday and Wednesday, despite showing daily gains. This comes amidst discussions around the appropriateness of the CEO’s compensation at Universal Health Services Inc. (NYSE:UHS). Allan B. Miller, the Founder, Chairman, and CEO of the nation’s largest hospital, has been at the center of these conversations.

A look at Universal Health Services, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Universal Health Services B, a healthcare management company, has been rated using Smartkarma Smart Scores on various factors. The company scores high in value and momentum, indicating a positive long-term outlook. With a strong focus on providing quality healthcare services such as general surgery and pediatric services, Universal Health Services B is positioned well for future growth and success.

However, the company’s scores in dividend and resilience are lower, suggesting some areas for improvement. Despite this, Universal Health Services B still maintains a decent overall outlook with a solid score in growth. As the company continues to expand its services across the United States and Puerto Rico, it will be interesting to see how they address these areas and further enhance their position in the healthcare industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma